Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by CytoSorbents

CytoSorbents Reports Third Quarter 2023 Financial and Operational Results
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents to Report Third Quarter 2023 Operating and Financial Results
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents to Present at the 8th Annual Dawson James Conference
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR Registry
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Announces Kathleen P. Bloch To Resume as Full-Time Chief Financial Officer
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorb with Ex Vivo Organ Perfusion: Transforming the Future of Solid Organ Transplantation
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Announces Resignation of Chief Financial Officer Alexander D’Amico
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Reports Second Quarter 2023 Financial and Operational Results
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents to Report Second Quarter 2023 Operating and Financial Results
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Appoints Alexander D’Amico as Chief Financial Officer
From CytoSorbents
Via GlobeNewswire
Tickers CSE:TRUL CTSO TCNNF
CytoSorbents And Humedics Announce Theranostic Collaboration in the Field of Liver Disease
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents This Week to Host its Virtual Annual Stockholders Meeting and to Present at the Jefferies Healthcare Conference
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Reports First Quarter 2023 Results
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents to Report First Quarter 2023 Operating and Financial Results
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents’ Pivotal STAR-T Trial Reaches Second Key Milestone With 80 Patients Enrolled
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Announces Board Chairman Al W. Kraus To Retire
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
Landmark Publication Underscores Robust Ability of CytoSorb to Reduce Cytokine Storm during Systemic Hyperinflammation
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Highlights New Clinical Data from Current Studies at the Live 42nd International Symposium on Intensive Care & Emergency Medicine (ISICEM)
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Comments on Bank Exposure and Diversified Cash Position
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
CytoSorbents Reports Fourth Quarter and Full Year 2022 Results
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
New European “Guidelines for the Management of Severe Perioperative Bleeding” Consider Hemoadsorption for the First-Time
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.